Current Location£ºProducts in IDL Application

Saljelly£¨Succinylated gelatin Injections£©

The active ingredient is Succinylated gelatin. Dossiers of marketing application are under preparation currently.

Succinylated gelatin Injections

Drug Name:

Succinylated gelatin Injections


Saljelly is a colloidal plasma substitute indicated for the initial management of hypovolaemic shock caused by, for example, haemorrhage, acute trauma or surgery, burns, sepsis, peritonitis, pancreatitis or crush injury. Saljelly may be used in the initial treatment of blood loss during pregnancy where plasma volume replacement is needed.

Registration Progress£º

Dossiers are under preparation.